Resumen
Background: Resistance to anti-TB drugs is influenced by personal characteristics and health conditions in developing countries. Aim: To determine the factors associated with pre-extensively drug-resistant tuberculosis (PRE XDR-TB) at Hospital Nacional Dos de Mayo (HNDM) in patients between the 2017 and 2019. Methods: An unpai-red case control study was developed; defining as case PRE XDR-TB patient and as control S-TB patient. Epidemiological, clinical and ra-diological variables were collected. Results: We analyzed 51 cases and 102 controls. The bivariate analysis showed as factors with p < 0.05 age ≥ 51 years (OR: 0.17, 95% CI: 0.05-0.51), drug use (OR: 2.5, 95% CI: 1.1-5.4), previous history of TB (OR: 20, 95% CI: 8.4-47), previous confinement (OR: 8, 95% CI: 2.7-23.8), HIV infection (OR: 0.2, 95% CI: 0.08-1) and previous use of antiTB drugs (OR: 21, 95% CI: 8.8-50). The logistic regression analysis identified as associated factors with PRE XDR-TB the previous contact with TB, a history of TB, length of illness and previous use of tuberculosis antibiotics. Conclusion: The measures to limit the development of TB-PRE XDR in patients with TB-S must include the previous history of TB, TB contact, length of illness and previous use of uncontrolled antibiotics against TB; however, there are inconclusive results about the harmful habits and comorbidity, requiring more studies to determine their influence as identifiable associated factors.
Título traducido de la contribución | Factors associated with pre-extensively drug-resistant tuberculosis in patients at Dos de Mayo National Hospital, Lima-Perú |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 491-497 |
- | 7 |
Publicación | Revista Chilena de Infectologia |
Volumen | 40 |
N.º | 5 |
DOI | |
Estado | Indizado - 2023 |
Publicado de forma externa | Sí |
Nota bibliográfica
Publisher Copyright:© 2023, Sociedad Chilena de Infectologia. All rights reserved.
Palabras clave
- associated factors and risk factors
- drug resistance multiple
- pre-extensively drug-resistant tuberculosis